Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9

被引:12
|
作者
Haupt, Amanda [1 ]
Grancharova, Tanya [1 ]
Arakaki, Joy [1 ]
Fuqua, Margaret A. [1 ]
Roberts, Brock [1 ]
Gunawardane, Ruwanthi N. [1 ]
机构
[1] Allen Inst Cell Sci, Seattle, WA 98109 USA
来源
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2018年 / 138期
关键词
Genetics; Issue; 138; Stem Cells; hiPSC; Molecular Biology; CRISPR; Cas9; Genome Engineering; Gene Knock-in; Gene Tagging; Fluorescent Protein; WEB TOOL; GENOME; CAS9; CHALLENGES; GENERATION; NUCLEASES; CHOPCHOP; DELIVERY; TALENS; ZFNS;
D O I
10.3791/58130
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A protocol is presented for generating human induced pluripotent stem cells (hiPSCs) that express endogenous proteins fused to in-frame N- or C-terminal fluorescent tags. The prokaryotic CRISPR/Cas9 system (clustered regularly interspaced short palindromic repeats/CRISPR-associated 9) may be used to introduce large exogenous sequences into genomic loci via homology directed repair (HDR). To achieve the desired knock-in, this protocol employs the ribonucleoprotein (RNP)-based approach where wild type Streptococcus pyogenes Cas9 protein, synthetic 2-part guide RNA (gRNA), and a donor template plasmid are delivered to the cells via electroporation. Putatively edited cells expressing the fluorescently tagged proteins are enriched by fluorescence activated cell sorting (FACS). Clonal lines are then generated and can be analyzed for precise editing outcomes. By introducing the fluorescent tag at the genomic locus of the gene of interest, the resulting subcellular localization and dynamics of the fusion protein can be studied under endogenous regulatory control, a key improvement over conventional overexpression systems. The use of hiPSCs as a model system for gene tagging provides the opportunity to study the tagged proteins in diploid, nontransformed cells. Since hiPSCs can be differentiated into multiple cell types, this approach provides the opportunity to create and study tagged proteins in a variety of isogenic cellular contexts.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Mitochondrial and Redox Modifications in Huntington Disease Induced Pluripotent Stem Cells Rescued by CRISPR/Cas9 CAGs Targeting
    Lopes, Carla
    Tang, Yang
    Anjo, Sandra, I
    Manadas, Bruno
    Onofre, Isabel
    de Almeida, Luis P.
    Daley, George Q.
    Schlaeger, Thorsten M.
    Carvalho Rego, Ana Cristina
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [32] Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells
    Kearns, Nicola A.
    Genga, Ryan M. J.
    Enuameh, Metewo S.
    Garber, Manuel
    Wolfe, Scot A.
    Maehr, Rene
    DEVELOPMENT, 2014, 141 (01): : 219 - 223
  • [33] An efficient and scalable pipeline for epitope tagging in mammalian stem cells using Cas9 ribonucleoprotein
    Dewari, Pooran Singh
    Southgate, Benjamin
    Mccarten, Katrina
    Monogarov, German
    O'Duibhir, Eoghan
    Quinn, Niall
    Tyrer, Ashley
    Leitner, Marie-Christin
    Plumb, Colin
    Kalantzaki, Maria
    Blin, Carla
    Finch, Rebecca
    Bressan, Raul Bardini
    Morrison, Gillian
    Jacobi, Ashley M.
    Behlke, Mark A.
    von Kriegsheim, Alex
    Tomlinson, Simon
    Krijgsveld, Jeroen
    Pollard, Steven M.
    ELIFE, 2018, 7
  • [34] Applications of TALENs and CRISPR/Cas9 in Human Cells and Their Potentials for Gene Therapy
    Niu, Jingwen
    Zhang, Bin
    Chen, Hu
    MOLECULAR BIOTECHNOLOGY, 2014, 56 (08) : 681 - 688
  • [35] CRISPR/Cas9-mediated gene knockout and interallelic gene conversion in human induced pluripotent stem cells using non-integrative bacteriophage-chimeric retrovirus-like particles
    Mianne, Joffrey
    Nasri, Amel
    Van, Chloe Nguyen
    Bourguignon, Chloe
    Fieldes, Mathieu
    Ahmed, Engi
    Duthoit, Christine
    Martin, Nicolas
    Parrinello, Hugues
    Louis, Anais
    Iche, Alexandra
    Gayon, Regis
    Samain, Florine
    Lamouroux, Lucille
    Bouille, Pascale
    Bourdin, Arnaud
    Assou, Said
    De Vos, John
    BMC BIOLOGY, 2022, 20 (01)
  • [36] Gene editing in mouse zygotes using the CRISPR/Cas9 system
    Wefers, Benedikt
    Bashir, Sanum
    Rossius, Jana
    Wurst, Wolfgang
    Kuehn, Ralf
    METHODS, 2017, 121 : 55 - 67
  • [37] CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein
    Tang, Lichun
    Zeng, Yanting
    Du, Hongzi
    Gong, Mengmeng
    Peng, Jin
    Zhang, Buxi
    Lei, Ming
    Zhao, Fang
    Wang, Weihua
    Li, Xiaowei
    Liu, Jianqiao
    MOLECULAR GENETICS AND GENOMICS, 2017, 292 (03) : 525 - 533
  • [38] The Application of CRISPR/Cas9 Technologies and Therapies in Stem Cells
    Scholefield J.
    Weinberg M.S.
    Current Stem Cell Reports, 2016, 2 (2) : 95 - 103
  • [39] p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells
    Ihry, Robert J.
    Worringer, Kathleen A.
    Salick, Max R.
    Frias, Elizabeth
    Ho, Daniel
    Theriault, Kraig
    Kommineni, Sravya
    Chen, Julie
    Sondey, Marie
    Ye, Chaoyang
    Randhawa, Ranjit
    Kulkarni, Tripti
    Yang, Zinger
    McAllister, Gregory
    Russ, Carsten
    Reece-Hoyes, John
    Forrester, William
    Hoffman, Gregory R.
    Dolmetsch, Ricardo
    Kaykas, Ajamete
    NATURE MEDICINE, 2018, 24 (07) : 939 - +
  • [40] Defining essential genes for human pluripotent stem cells by CRISPR-Cas9 screening in haploid cells
    Yilmaz, Atilgan
    Peretz, Mordecai
    Aharony, Aviram
    Sagi, Ido
    Benvenisty, Nissim
    NATURE CELL BIOLOGY, 2018, 20 (05) : 610 - +